beta-catenin-IN-3 (Compound C2) is a selective beta-catenin inhibitor. beta-catenin-IN-3 binds to allosteric site on the surface of beta-catenin with K D calculated at 54.96 nM. beta-catenin-IN-3 selectively inhibits beta-catenin via targeting a cryptic allosteric modulation site, lowers its cellular load. beta-catenin-IN-3 significantly reduces viability of beta-catenin driven cancer cells, and triggers beta-catenin degradation via proteasome system in beta-catenin-overexpressing cancer cells[1].
Molekulargewicht:
484.25
Reinheit:
98.03
CAS Nummer:
[1005288-15-2]
Formel:
C19H20Br2N2OS
Target-Kategorie:
CDK,Wnt,beta-catenin
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten